Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Harte Hanks Acquires Exclusive Rights to License ADS Data Direct's Premier Medical Ailment Database

Strategic Licensing Rights Strengthen Harte Hanks' Leadership in Compliant, High-Precision Healthcare Marketing

CHELMSFORD, MA / ACCESS Newswire / June 2, 2025 / Harte Hanks (NASDAQ: HHS), a global leader in customer experience and data-driven marketing, today announced that it has obtained exclusive rights to license ADS Data Direct's (ADS) industry-leading Medical Ailment Database, with limited client exceptions. This transformative undertaking positions Harte Hanks as the controller of one of the most comprehensive, HIPAA-compliant health data assets available in the market, delivering unmatched value to healthcare marketers.

ADS's Medical Ailment Database, sourced through the Healthier Me Today platform, provides access to 100% triple opt-in consumers who have self-identified as living with specific health conditions across more than 200 ailment categories. This valuable data asset enhances Harte Hanks' ability to deliver superior targeting precision, campaign performance, and compliance assurance for clients in the pharmaceutical, medical device, and broader healthcare sectors.

"The exclusive licensing right to this high-integrity database is a strategic milestone for Harte Hanks, deepening our commitment to delivering unparalleled data solutions that empower healthcare and health-related marketers," said Teresa Gavin, VP of Data Solutions at Harte Hanks. "We are now better positioned than ever to help our clients engage the right consumers-ethically, effectively, and with measurable impact."

The Medical Ailment Database is distinguished by its depth and reliability, capturing self-reported health data through rigorous HIPAA-compliant processes on the Healthier Me Today platform. It is purpose-built to support campaigns targeting individuals managing conditions such as diabetes, arthritis, heart disease, mental health disorders, and many more.

ADS is a premium provider of precision-targeted marketing solutions, offering proprietary data assets that drive scalable lead generation and engagement strategies across digital, mobile, email, and direct mail channels.

"Harte Hanks' licensing rights to our flagship health database reflects their vision and leadership in data-driven marketing," said Eric Nelson, President & Managing Partner of ADS Data Direct. "We are confident that their expertise and strategic focus will unlock the full potential of this asset, delivering exceptional value to healthcare and health-related marketers."

For media inquiries or to learn more about the Medical Ailment Database, please contact:
Cindy Stein
Global Head of Marketing
Harte Hanks
cindy.stein@hartehanks.com
www.HarteHanks.com

SOURCE: Harte Hanks, Inc.



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.